Arrow Mark Colorado Holdings LLC Immuno Gen, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $452,148 - $1.09 Million	36,288 Added 22.06%	200,780 $5.95 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $616,845 - $3.3 Million	164,492 New	164,492 $3.1 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $2.32 Million - $3.55 Million	-1,046,376 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $3.14 Million - $5.77 Million	-1,746,975 Reduced 62.54%	1,046,376 $2.27 Million
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $1.96 Million - $4.81 Million	-813,373 Reduced 22.55%	2,793,351 $7.57 Million

Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $6.61 Million - $16.3 Million	1,678,774 Added 87.08%	3,606,724 $17.3 Million
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $16.6 Million - $21.7 Million	1,927,950 New	1,927,950 $18.3 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.